Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Docci

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Nephron|January 1, 1986
What plasma antithrombin III after hemodialysis?D Docci, R Bilancioni, F Turci, et al.
Nephron|January 1, 1989
Evidence of some nonglomerular bleeding in IgA nephropathyD Docci, L Baldrati, F Turci, et al.
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio|December 1, 1985
[Hyperlipidemia in uremic patients in dialysis]D Docci, R Bilancioni, F Turci, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Serum lipoprotein(a) (Lpa(a)) in haemodialysis patientsD Docci, L Baldrati, C Capponcini, et al.
American Journal of Nephrology|January 1, 1992
Immunogenicity of a recombinant hepatitis B vaccine in hemodialysis patientsD Docci, L Baldrati, C Capponcini, et al.
Nephron|January 1, 1988
Serum angiotensin-converting enzyme is not an indicator of dialyzer membrane biocompatibilityD Docci, F Turci, L Baldrati, et al.
Giornale Di Clinica Medica|April 1, 1980
[Renal and metabolic effects of protracted hydropenic therapy]A Vangelista, L Perini, L Colì, et al.
Nephron|January 1, 1989
Plasma zinc decreases in hemodialysis patients treated with calcium carbonate as the phosphate binderP Gilli, D Docci, L Baldrati, et al.
Clinical Nephrology|September 1, 1986
Effect of ibopamine on the progression of chronic renal failureD Docci, E Pistocchi, F Turci, et al.
Giornale Di Clinica Medica|April 1, 1981
[Therapy of uremic osteodystrophy]C Fletti, D Docci, L Coli', et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Nephron|January 1, 1986
What plasma antithrombin III after hemodialysis?D Docci, R Bilancioni, F Turci, et al.
Nephron|January 1, 1989
Evidence of some nonglomerular bleeding in IgA nephropathyD Docci, L Baldrati, F Turci, et al.
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio|December 1, 1985
[Hyperlipidemia in uremic patients in dialysis]D Docci, R Bilancioni, F Turci, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Serum lipoprotein(a) (Lpa(a)) in haemodialysis patientsD Docci, L Baldrati, C Capponcini, et al.
American Journal of Nephrology|January 1, 1992
Immunogenicity of a recombinant hepatitis B vaccine in hemodialysis patientsD Docci, L Baldrati, C Capponcini, et al.
Nephron|January 1, 1988
Serum angiotensin-converting enzyme is not an indicator of dialyzer membrane biocompatibilityD Docci, F Turci, L Baldrati, et al.
Giornale Di Clinica Medica|April 1, 1980
[Renal and metabolic effects of protracted hydropenic therapy]A Vangelista, L Perini, L Colì, et al.
Nephron|January 1, 1989
Plasma zinc decreases in hemodialysis patients treated with calcium carbonate as the phosphate binderP Gilli, D Docci, L Baldrati, et al.
Clinical Nephrology|September 1, 1986
Effect of ibopamine on the progression of chronic renal failureD Docci, E Pistocchi, F Turci, et al.
Giornale Di Clinica Medica|April 1, 1981
[Therapy of uremic osteodystrophy]C Fletti, D Docci, L Coli', et al.
Pageof 8